下肢静脈瘤治療市場 - 世界の産業規模、シェア、動向、機会、予測：タイプ別、コンポーネント別、エンドユーザー別、地域別、競合、2020年～2030年

下肢静脈瘤治療の世界市場規模は2024年に14億5,000万米ドルで、2030年には20億8,000万米ドルに達し、予測期間中のCAGRで6.32%の成長が予測されています。

世界の下肢静脈瘤治療市場は、静脈疾患に対する意識の高まりと低侵襲手術の需要の高まりにより、大きな成長を遂げています。

例えば、ドイツのInstitute of Quality and Efficiency in Healthcareの調査によると、成人のおよそ20％が人生のどこかで静脈瘤を経験すると推定されています。クモ状静脈は高齢者の間でより一般的ですが、若い人もこれらの静脈疾患に罹患する可能性があります。下肢静脈瘤は、静脈弁の欠陥によって静脈が拡大したりねじれたりすることで生じますが、特に高齢化した人々や座りっぱなしのライフスタイルの人々の間で、より一般的になってきています。美容と健康の両方の理由で治療を求める患者が増える中、医療プロバイダーは効果的な治療オプションを拡大しつつあります。レーザー治療、ラジオ波焼灼術、硬化療法における技術の進歩は、治療の状況を一変させ、回復時間の短縮、痛みの軽減、傷跡の最小化をもたらしています。これらの技術革新により、外来患者による治療がより身近で魅力的なものとなり、市場の普及を後押ししています。

主な市場促進要因

下肢静脈瘤および静脈疾患の有病率の上昇

主な市場課題

高い治療費

主な市場動向

静脈内レーザーアブレーション（EVLA）の急速な普及

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の下肢静脈瘤治療市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • タイプ別（静脈内アブレーション、硬化療法、外科的結紮術・ストリッピング術）
  • コンポーネント別（アブレーションデバイス、高周波アブレーションデバイス、レーザーアブレーションデバイス、静脈閉鎖製品、その他）
  • エンドユーザー別（病院・診療所、外来診療センター、その他）
  • 地域別
  • 企業別（2024）
• 市場マップ
  • タイプ別
  • コンポーネント別
  • エンドユーザー別
  • 地域別

第6章 北米の下肢静脈瘤治療市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第7章 欧州の下肢静脈瘤治療市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋地域の下肢静脈瘤治療市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米の下肢静脈瘤治療市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの下肢静脈瘤治療市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 合併と買収
• 製品上市

第13章 競合情勢

• Alma Lasers Limited
• Medtronic Plc.
• Boston Scientific Corporation（Lumenis Corporation）
• Sciton, Inc
• Merit Medical Systems, Inc.
• BTG International Limited
• Energist Limited
• Teleflex Incorporated
• AngioDynamics, Inc.
• El. En SpA Group（Quanta System）

第14章 戦略的提言

第15章 調査会社について・免責事項

Global Varicose Veins Treatment Market was valued at USD 1.45 billion in 2024 and is expected to reach USD 2.08 billion by 2030 with a CAGR of 6.32% during the forecast period. The global varicose veins treatment market is experiencing significant growth due to increasing awareness of venous disorders and the rising demand for minimally invasive procedures.

For instance, according to the study from Germany's Institute of Quality and Efficiency in Healthcare estimates that roughly 20% of adults will experience varicose veins at some point in their lives. Although spider veins are more prevalent among the elderly, younger people can also be affected by these venous conditions. Varicose veins, which occur when veins become enlarged and twisted due to faulty valves, are becoming more prevalent, especially among aging populations and individuals with sedentary lifestyles. With more patients seeking medical attention for both cosmetic and health reasons, healthcare providers are expanding their offerings for effective treatment options. Technological advancements in laser therapy, radiofrequency ablation, and sclerotherapy are transforming the treatment landscape, offering quicker recovery times, reduced pain, and minimal scarring. These innovations have made outpatient procedures more accessible and appealing to patients, boosting market adoption.

Key Market Drivers

Rising Prevalence of Varicose Veins and Venous Disorders

The rising prevalence of varicose veins and venous disorders is a major factor driving the growth of the global varicose veins treatment market. Varicose veins are a common condition characterized by swollen, twisted veins that most often occur in the legs due to weak or damaged vein walls and valves. Several contributing factors have led to an increase in cases worldwide. Aging is a primary risk factor, as vein elasticity naturally declines over time, making older adults more susceptible. Hormonal changes, particularly during pregnancy and menopause, also contribute to the weakening of vein walls, increasing the likelihood of varicose vein development, especially among women. Obesity and a sedentary lifestyle are closely linked to venous insufficiency. Excess body weight places additional pressure on leg veins, while prolonged sitting or standing impairs circulation and contributes to valve dysfunction. These lifestyle patterns are increasingly common across both developed and developing nations, resulting in a higher burden of venous disorders. Occupational risk is another concern, with many individuals in professions requiring long hours of standing or sitting-such as healthcare workers, teachers, and office employees-experiencing higher susceptibility.

As awareness of varicose veins has grown, more individuals are seeking medical care not only for physical symptoms such as pain, swelling, and heaviness in the legs but also for cosmetic concerns. Patients are becoming more proactive about managing early signs of venous disorders to prevent complications like chronic venous insufficiency, ulcers, and deep vein thrombosis. This rising demand for diagnosis and intervention is pushing healthcare systems and providers to invest in advanced treatment options. The increasing prevalence across diverse population segments continues to generate significant momentum for innovation and expansion within the varicose veins treatment market, as the need for effective, accessible, and minimally invasive solutions becomes more urgent.

Key Market Challenges

High Treatment Costs

High treatment costs remain one of the major challenges impacting the global varicose veins treatment market. Although minimally invasive procedures have transformed care by offering better outcomes and faster recovery, they often come at a premium. Techniques such as endovenous laser treatment (EVLT), radiofrequency ablation (RFA), and ultrasound-guided foam sclerotherapy require advanced medical equipment, skilled professionals, and precise imaging systems. These elements drive up the overall cost of diagnosis and treatment, making it less accessible for a large segment of the population, especially in low- and middle-income countries. The financial burden is compounded by the fact that varicose vein treatments are frequently categorized as elective or cosmetic in nature, which limits insurance coverage or reimbursement eligibility. Many insurance providers do not cover these procedures unless there is documented evidence of medical necessity, such as chronic pain, ulceration, or venous insufficiency. As a result, out-of-pocket expenses can be substantial, deterring patients from seeking timely care.

In public healthcare systems, cost constraints can lead to long wait times and limited access to specialized care, particularly when prioritization is given to life-threatening conditions. Private healthcare facilities, while offering advanced treatments with minimal delays, often remain financially out of reach for a large portion of the population. This cost-related disparity results in delayed intervention, increased complication rates, and higher long-term healthcare expenses. Healthcare providers and manufacturers are working to address this challenge by introducing cost-effective technologies and expanding the use of outpatient treatment settings, which can help reduce hospital overhead. However, until there is broader access to affordable treatment and improved insurance support, high costs will continue to be a barrier for many patients. This challenge underscores the need for strategic pricing, wider public healthcare funding, and awareness around the long-term benefits of early varicose vein treatment.

Key Market Trends

Rapid Adoption of Endovenous Laser Ablation (EVLA)

The rapid adoption of endovenous laser ablation (EVLA) is significantly transforming the global varicose veins treatment market. EVLA has emerged as a preferred treatment method for varicose veins due to its minimally invasive nature, high success rate, and faster recovery compared to traditional surgical procedures like vein stripping. Patients and physicians alike are drawn to its clinical advantages, including reduced postoperative pain, minimal scarring, and a low risk of complications. These benefits align well with the growing demand for outpatient procedures that offer convenience without compromising effectiveness. EVLA uses targeted laser energy to seal faulty veins, causing them to collapse and eventually be absorbed by the body. The procedure is typically performed under local anesthesia, allowing patients to return to daily activities within a short period. This efficiency has made EVLA a go-to option for individuals seeking both functional and cosmetic relief from varicose veins. As awareness spreads about its effectiveness and safety profile, healthcare providers are increasingly incorporating EVLA into their service offerings. The availability of advanced laser systems with improved wavelength control, cooling technologies, and fiber-optic precision is further accelerating the use of EVLA in clinical practice. Medical device companies are actively investing in research and development to enhance system performance and user experience, ensuring better patient outcomes and procedure efficiency. Clinics and hospitals are adopting these technologies to stay competitive and meet patient expectations for modern, less invasive solutions. With insurance providers beginning to recognize the long-term cost savings of minimally invasive treatments like EVLA, reimbursement support is also gradually improving in some regions. This shift is helping to make the procedure more accessible. As the market continues to favor less invasive approaches, the role of EVLA is expected to grow, solidifying its place as a key driver of innovation and expansion in varicose vein management.

Key Market Players

• Alma Lasers Limited
• Medtronic Plc.
• Boston Scientific Corporation (Lumenis Corporation)
• Sciton, Inc
• Merit Medical Systems, Inc.
• BTG International Limited
• Energist Limited
• Teleflex Incorporated
• AngioDynamics, Inc.
• El. En SpA Group (Quanta System)

Report Scope:

In this report, the Global Varicose Veins Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Varicose Veins Treatment Market, By Type:

• Endovenous Ablation
• Sclerotherapy
• Surgical Ligation & Stripping

Varicose Veins Treatment Market, By Component:

• Ablation Devices
• Radiofrequency Ablation Devices
• Laser Ablation Devices
• Venous Closure Products
• Others

Varicose Veins Treatment Market, By End User:

• Hospitals & Clinics
• Ambulatory Care Centers
• Others

Varicose Veins Treatment Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Varicose Veins Treatment Market.

Available Customizations:

Global Varicose Veins Treatment Market report with the given Market data, TechSci Research, offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional Market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Varicose Veins Treatment Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Endovenous Ablation, Sclerotherapy, Surgical Ligation & Stripping)
  • 5.2.2. By Component (Ablation Devices, Radiofrequency Ablation Devices, Laser Ablation Devices, Venous Closure Products, Others)
  • 5.2.3. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map
  • 5.3.1. By Type
  • 5.3.2. By Component
  • 5.3.3. By End User
  • 5.3.4. By Region

6. North America Varicose Veins Treatment Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Component
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Varicose Veins Treatment Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Component
      • 6.3.1.2.3. By End User
  • 6.3.2. Mexico Varicose Veins Treatment Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Component
      • 6.3.2.2.3. By End User
  • 6.3.3. Canada Varicose Veins Treatment Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Component
      • 6.3.3.2.3. By End User

7. Europe Varicose Veins Treatment Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Component
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Varicose Veins Treatment Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Component
      • 7.3.1.2.3. By End User
  • 7.3.2. Germany Varicose Veins Treatment Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Component
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Varicose Veins Treatment Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Component
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Varicose Veins Treatment Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Component
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Varicose Veins Treatment Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Component
      • 7.3.5.2.3. By End User

8. Asia-Pacific Varicose Veins Treatment Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Component
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Varicose Veins Treatment Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Component
      • 8.3.1.2.3. By End User
  • 8.3.2. India Varicose Veins Treatment Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Component
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Varicose Veins Treatment Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Component
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Varicose Veins Treatment Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Component
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Varicose Veins Treatment Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Component
      • 8.3.5.2.3. By End User

9. South America Varicose Veins Treatment Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Component
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Varicose Veins Treatment Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Component
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Varicose Veins Treatment Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Component
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Varicose Veins Treatment Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Component
      • 9.3.3.2.3. By End User

10. Middle East and Africa Varicose Veins Treatment Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Component
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Varicose Veins Treatment Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Component
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Varicose Veins Treatment Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Component
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Varicose Veins Treatment Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Component
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Competitive Landscape

• 13.1. Alma Lasers Limited
  • 13.1.1. Business Overview
  • 13.1.2. Company Snapshot
  • 13.1.3. Products & Services
  • 13.1.4. Financials (As reported)
  • 13.1.5. Recent Developments
  • 13.1.6. SWOT Analysis
• 13.2. Medtronic Plc.
• 13.3. Boston Scientific Corporation (Lumenis Corporation)
• 13.4. Sciton, Inc
• 13.5. Merit Medical Systems, Inc.
• 13.6. BTG International Limited
• 13.7. Energist Limited
• 13.8. Teleflex Incorporated
• 13.9. AngioDynamics, Inc.
• 13.10. El. En SpA Group (Quanta System)

14. Strategic Recommendations

15. About Us & Disclaimer